| 000 | 01836 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516203816.0 | ||
| 264 | 0 | _c20150128 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/1471-2334-14-166 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelsing, Corine E | |
| 245 | 0 | 0 |
_aInterferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cMar 2014 |
||
| 300 |
_a166 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnidulafungin |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAspergillosis _xdrug therapy |
| 650 | 0 | 4 |
_aCandidiasis, Invasive _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aEchinocandins _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aInterferon-gamma _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 700 | 1 | _aGresnigt, Mark S | |
| 700 | 1 | _aLeentjens, Jenneke | |
| 700 | 1 | _aPreijers, Frank | |
| 700 | 1 | _aFrager, Florence Allantaz | |
| 700 | 1 | _aKox, Matthijs | |
| 700 | 1 | _aMonneret, Guillaume | |
| 700 | 1 | _aVenet, Fabienne | |
| 700 | 1 | _aBleeker-Rovers, Chantal P | |
| 700 | 1 | _avan de Veerdonk, Frank L | |
| 700 | 1 | _aPickkers, Peter | |
| 700 | 1 | _aPachot, Alexandre | |
| 700 | 1 | _aKullberg, Bart Jan | |
| 700 | 1 | _aNetea, Mihai G | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 14 _gp. 166 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2334-14-166 _zAvailable from publisher's website |
| 999 |
_c23677657 _d23677657 |
||